Business ❯ Healthcare ❯ Pharmaceuticals

Market Trends

Novo Nordisk Product Launches Sales Performance Revenue Growth GLP-1 Drugs Vaccine Industry Weight Loss Drugs Consumer Health Products Generic Products Revenue Projections

Eli Lilly Trades at a High Multiple as GLP‑1 Catalysts Loom

Near‑term regulatory decisions and launch results will determine whether investors’ big growth bet on the company is justified.

Pfizer CFO Dave Denton to Exit and Cecile Guegan Named Interim

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Merck Reports Q1 Loss From Cidara Charge as Sales Beat and 2026 Outlook Rises

Novo Nordisk Strikes Hims & Hers Deal for Ozempic and Wegovy, Drops Patent Suit

Sanofi Names Merck’s Belén Garijo Chief Executive After April Vote

Sanofi Replaces Paul Hudson, Names Belén Garijo as Next CEO

HSBC Upgrades AbbVie to Buy, Lifts Target to $265 as Skyrizi and Rinvoq Drive Growth

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

Eli Lilly Briefly Hits $1 Trillion, First Drugmaker to Reach the Milestone

Takeda Names Julie Kim as First Female CEO in Company's 240-Year History

Roche Accelerates Development of Promising Weight-Loss Pills